KWM
IBB icon

Kingsview Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Kingsview Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-400
Closed -$1K – 461
2019
Q2 		$1K Buy
+400
New +$42.5K ﹤0.01% 441
2017
Q4 		– Sell
-3,000
Closed -$5K – 411
2017
Q3 		$5K Sell
3,000
-23,100
-89% -$2.47M ﹤0.01% 302
2017
Q2 		$13K Buy
+26,100
New +$2.57M 0.01% 263

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Kingsview Wealth Management's IBB Position: Q2 2026 in Review

Kingsview Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 5.3% in Q2 2026, buying an estimated $33K and bringing the position to 3,833 shares worth $729K. The position accounts for 0.01% of the portfolio, ranked #845.

Kingsview Wealth Management first reported a position in IBB in Q1 2017 and has held it in 38 quarters since. The position peaked at $4.24M in Q4 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Kingsview Wealth Management held 3,833 shares of iShares Biotechnology ETF worth $729K as of Q2 2026.
  • Kingsview Wealth Management bought 192 iShares Biotechnology ETF shares in Q2 2026, an estimated $33K.
  • iShares Biotechnology ETF made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #845 holding.
  • Kingsview Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 38 quarters since.
  • Kingsview Wealth Management's iShares Biotechnology ETF position peaked at $4.24M in Q4 2024.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.